The first IPO of the European weed company was successful. The shares increased by 300 percent in the first minutes of the stock market entry. Stenocare went public for € 1.18. A few tens of minutes later it was € 4.50. Stenocore is the first company to have a license for importing and exporting cannabis oil!

With the income from the grant (2.5 million euros), Stenocare wants to invest in their own production facility. According to internal experts, this is necessary to be able to meet the demand that is emerging.